APAC Lipid Panel Testing Market - Industry Trends and Forecast to 2030
Asia-Pacific Lipid Panel Testing Market, By Products & Services (Devices, Kits, and Services), Prescription Mode (Prescription Based Testing and OTC Based Testing), Application (Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hypolipoproteinemia, Tangier Disease, Atherosclerosis. and Others), End User (Hospitals, Specialty Clinics & Physician Offices, Pathology Laboratories, Diagnostic Clinics, Ambulatory Surgical Centers, Reference Laboratories, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender, Retail Pharmacy, Online Sales, and Others), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific) Industry Trends and Forecast to 2030
Market Definition
A lipid panel is a common blood test healthcare providers use to monitor and screen for cardiovascular disease risk. The panel includes three cholesterol measurements as well as a triglyceride measurement.
Healthcare providers use lipid panels to assess someone's cardiovascular health by analyzing cholesterol in their blood and to help diagnose other health conditions. The lipid panel assesses the presence of specific fat molecules known as lipids in the blood. It measures multiple substances as a panel test, including several cholesterol-containing molecules. The lipid panel assesses the risk of cardiovascular diseases such as heart disease, heart attack, and stroke in children and adults.
Market Segmentation
The Asia-Pacific lipid panel testing market is categorized into five notable segments: products and services, prescription mode, application, end user, and distribution channel.
• On the basis of products & services the Asia-Pacific lipid panel testing market is segmented into devices, kits, and services
• On the basis of prescription mode, the Asia-Pacific lipid panel testing market is segmented into prescription based testing and OTC based testing
• On the basis of application, the Asia-Pacific lipid panel testing market is segmented into hyperlipidemia, hypertriglyceridemia, familial hypercholesterolemia, hypolipoproteinemia, tangier disease, atherosclerosis, and others
• On the basis of end user, the Asia-Pacific lipid panel testing market is segmented into hospitals, specialty clinics & physician offices, pathology laboratories, diagnostic clinics, ambulatory surgical centers, reference laboratories, academic and research institutes, and others
• On the basis of distribution channel, the Asia-Pacific lipid panel testing market is segmented into direct tender, retail pharmacy, online sales, and others
Market Players
Some major companies dealing in the Asia-Pacific lipid panel testing market are:
• Nova Biomedical
• Spark Diagnostics Pvt. Ltd.
• Everlywell, Inc.
• HORIBA Medical
• Abbott
• F. Hoffmann-La Roche Ltd.
• SD Biosensor, INC.
• Elitech Group
• Randox Laboratories Ltd.
• Diatron
• Siemens Healthcare GmbH
• Sinocare
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• myLAB Box
• Awareness Technology, Inc.
• Croda International Plc.
• Eurofins Scientific
• Boston Heart Diagnostics Corporation
• cpc diagnostics
• PTS Diagnostics
• ARUP Laboratories
• Laboratory Corporation of America Holdings
• EKF Diagnostics
• Beckman Coulter, Inc. (Subsidiary of Danaher)
• Sekisui Diagnostics (A Part of SEKISUI Chemical Co. Ltd.).
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook